Sol_Doc_75F40125R00037_Attachment 1 - Data Characteristics Table.pdf

Access to Outpatient Longitudinal Data IDIQ 75F40125R00037

Attachment 1

ATTACHMENT 1. DATA CHARACTERISTICS TABLE

Outpatient Prescription and Patient Level Data Characteristics Table:

(All items are required unless stated as “if available” please provide description or state as Y/N with explanation or description) A description of the overall population and data characteristics Month and year of when data collection began The total number of years of data available, specify online or by request The amount of data available online on a standard basis The ability of accessing historical data that is no longer online [Y/N]; if yes, how many years?

The lag time between date of service and online availability of all types of data available Description of the data source, type of data, and full disclosure of collection and projection methodology demonstrating that the resource can evaluate drug utilization data The availability of confidence intervals around any projected estimates and the method used to calculate [Y/N] Description of data de-identification method The demographic distribution of prescriber specialties (to include numbers and percents) compared to an appropriate national benchmark (e.g. national professional society memberships such as AMA) Availability of outpatient prescription and patient-level data by US Census region (Northeast, Midwest, South, West) (listed in Attachment 5) [Y/N] Age – Specify method by which patient age is obtained and how it is displayed in reports, i.e., standard age groups, customized age groups, single years) Availability of prescription and patient-level data by patient sex [Y/N] Availability of prescription and patient-level data by all payment method (including non-adjudicated claims, e.g. payment by cash) [Y/N] Availability of prescription and patient-level data by prescriber specialty [Y/N] Availability of prescription and patient-level data by setting of care [Y/N] Availability of prescription and patient-level data by race/ethnicity (if available) [Y/N] Availability of unique counts of prescribers [Y/N] A description and information relating to any projection or other appropriate methodology and methods fully disclosed; the demographic distribution of prescriptions, patients, prescribers, and other utilization metrics (to include numbers and percent) compared to an appropriate national benchmark (e.g. national professional society memberships such as the AMA, CDC data) by age (10 year increments), gender, type of practitioner, and the four census regions (Northeast, Midwest, South, West); the frequency distribution of patient-level characteristics associated with patients (to include numbers and percent).

Overall number of prescribers, prescriber specialties, prescriptions, and patients represented in the entire database Ability to identify and stratify patient level data as human versus non-human (e.g., prescriptions written by veterinarians) [Y/N] Overall number of pharmacies or settings of care represented in the entire database (if available) A description of the drug coding system used, including the number of drug coding levels available A description of clinical or medical coding system used, including number of levels of clinical or medical coding

Access to Outpatient Longitudinal Data IDIQ 75F40125R00037

Attachment 1

Outpatient Prescription and Patient Level Data Characteristics Table:

(All items are required unless stated as “if available” please provide description or state as Y/N with explanation or description) Ability to capture the administration of drug or biologic products using claims data in the outpatient setting by healthcare professionals [Y/N] Availability of other outpatient settings of care, e.g., mail-order, specialty pharmacies, outpatient clinics, long-term care facilities, and the proportion represented in the database [Y/N] Availability of product strength [Y/N] Availability of product form [Y/N] Availability of package size of drug product by mL, number of tablets/capsules available [Y/N] Availability of daily dose and duration of medication consumption (in days, months, years) (if available) [Y/N] Availability of market, drug class, product brand, branded generic, generic, and molecule level data [Y/N] Availability of manufacturer, company and corporation for product level data [Y/N] Ability to assess concomitant use by drug class, product brand, branded generic, generic, and molecule level data [Y/N] Ability to identify and quantify new prescriptions versus refill prescriptions [Y/N] Ability to identify and quantify switch/add-on prescriptions (if available) [Y/N] Ability to have user-defined look back period of previous therapy (if available) [Y/N] Ability to capture prescriptions dispensed prior to and switched from the selected therapy (if available) [Y/N] Ability to capture prescriptions as originally written by the prescriber and how it was ultimately dispensed, e.g., Dispensed as Written, Substitutions (if available) [Y/N] ICD-9 and ICD-10 diagnosis codes [Y/N] Concomitant ICD-9 and ICD-10 diagnosis codes [Y/N] The percentage of missing or incomplete information for each data element [Y/N] Complete data dictionary (including percentage of missing data) If any of the following data elements are not available at the prescription or patient level, the Offeror shall explain under what conditions data are aggregated, and the method of aggregation: patient-specific, drug-specific, diagnosis-specific, and health care practitioner-specific A description of Offeror’s business that specifically details the percentage of data committed for outpatient prescription or patient level data. In addition, the Offeror shall provide the largest percentage of any single data provider Raw/sample numbers, as well as projected numbers; and the frequency with which data are updated and methods for updates Interface documentation (white paper, training manual, etc.)

Ability to receive e-mail confirmation when reports are complete, if applicable Method and frequency for updating interface Method of simultaneous, multi-user access and number and nature of limits to access, including numbers of users, numbers and types of data elements Past history of scheduled and unscheduled downtime of data Capability and methods for end-user downloading data, including maximum number of records (number of rows and file size) and formats available

ATTACHMENT 1. DATA CHARACTERISTICS TABLE